XML 49 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENTS, GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of financial information with respect to single operating segment
   
Year ended December 31,
 
   
2024
   
2023
   
2022
 
                   
Total Revenues
 
$
27,864
   
$
33,459
   
$
7,500
 
Less:
                       
          R&D expenses
                       
               Preclinical
   
15,374
     
20,948
     
17,477
 
               Clinical
   
15,267
     
10,627
     
11,357
 
           SG&A
   
9,485
     
9,320
     
9,690
 
           Financial income, net
   
(5,182
)
   
(3,215
)
   
(1,738
)
           Taxes on income
   
4,522
     
8,970
     
58
 
           Other segment expenses*
   
2,629
     
5,563
     
4,350
 
                         
Net loss
 
$
(14,231
)
 
$
(18,754
)
 
$
(33,694
)
Schedule of total revenues and long-lived assets by geographic area
   
Year ended December 31,
 
   
2024
   
2023
   
2022
 
Revenue from sales to customers:
                 
                   
Europe
 
$
5,000
   
$
10,000
   
$
7,500
 
United States
   
22,864
     
23,459
     
-
 
                         
Total revenue
 
$
27,864
   
$
33,459
   
$
7,500
 
 
   

December 31,

   
2024
   
2023
 
Long-lived assets:
           
             
Israel
 
$
3,677
   
$
2,468
 
United States
   
18
     
77
 
                 
Total long-lived assets
 
$
3,695
   
$
2,545
 
Schedule of sales to single customer exceeding 10%
   
Year ended December 31,
 
   
2024
   
2023
   
2022
 
Sales to a single customer exceeding 10%:
                 
                   
Customer A
   
18
%
   
30
%
   
100
%
Customer B
   
82
%
   
70
%
   
-